News

An expert discusses which types of products tend to be more comdedogenic and acnegenic.

An expert discusses available types of facial foundations and their effect on the skin in regards to acne.

Agents that can attack melasma on multiple fronts include retinoids, glucosamine, hydroquinone, topical steroids, phytosterol, glycyrrhetinic acid, niacinamide, soybean extracts, retinoids, salicylic acid and liquirtin, an expert says.

A new study using crowdsourcing harnesses the power of social media chatter to better understand unmet needs in eczema research.

Tickborne diseases are a significant health problem in the United States with over 40,000 confirmed or probable cases reported as recently as 2014. Almost 80% of these cases consist of Lyme disease, but other diseases, including viral infections, are present and have been increasing in number over the past 20 years. Experts in tickborne diseases share updates about what’s new and what’s changing in the detection and transmission of these diseases.

A report published by U.S. based market research company Grand View Research suggests the global skincare products market will reach $196.67 billion by 2024, up from an estimated $129.21 billion in 2015.

Skincare product formulating is a natural for dermatologists, but there are several important considerations before starting what can be an expensive, time-consuming process.

Managing referrals successfully requires being honest with patients and equitable with peers, experts say.

There are important differences in and misconceptions about the prevalence, clinical presentation and treatment of skin of color versus Caucasian psoriasis patients. Dermatologist Andrew F. Alexis, M.D., M.P.H., share his insight about what dermatologists need to know when treating psoriasis skin of color patients.

Based on available evidence, dermatologists should at least discuss biologic drugs with patients who have moderate-to-severe psoriasis and cardiovascular comorbidities. Clearing the skin may improve cardiovascular disease, says an expert.

Many children with eczema suffer from bullying because of the skin condition. A new survey reflects what children and caregivers are experiencing, beyond the itch.

Microbial colonization in the development of inflammatory conditions and immune-mediated conditions is a hot research topic, and new dermatologic therapies can potentially result from greater understanding of the role of microbial communities on the skin and in the gut.

This month we offer new insights and data to aid diagnosis and treatment of difficult conditions, as well as practical approaches to optimize outcomes.

The FDA approved the biosimilars Erelzi for plaque psoriasis and Enbrel for psoriatic arthritis.

John Kimbrough, a librarian at Georgetown University, sits down with Dermatology Times Editorial Advisor, Elaine Siegfried, MD to talk about his work with citation analysis of cutaneous t-cell lymphoma.

For patients who need or want alternative approaches for treating psoriasis, balenotherapy, curcumin, indigo naturalis, fish oil supplementation, and dietary control may provide effective relief, either alone or as integrative therapy.

Oluwatobi A. Ogbechie, MD, MBA discusses her 2016 AAD Poster, "Measuring the costs of shave and punch biopsy techniques using time-driven activity-based costing" with Dermatology Times Editorial Advisor, Elaine Siegfried, MD.

Third-year Stanford Medical School student, Akhilesh Pathipati, discusses his 2016 AAD poster, “Implementation of Stanford Health Care Direct-Care Teledermatology Program” with Dermatology Times Editorial Advisor, Elaine Siegfried, MD.

Andrew T. Patterson, MD sits down with Dermatology Times Editorial Advisor, Elaine Siegfried, MD to discuss his 2016 AAD poster, “Skin diseases associated with Agent Orange and other organochlorine exposures.”

Researchers report in a new in vitro study published in Endocrinology that 13 of the 29 ultraviolet (UV) filters they looked at interfere with sperm function.

Foundation Medicine, based in Cambridge, Mass., announced in late August the addition of new clinical markers to its genomic profile products FoundationOne and FoundationOne Heme.

Pediatric atopic dermatitis and acne have some similarities when these present in skin of color and lighter-skin children. But there are important differences when these common skin conditions affect darker skin types. An expert discusses how treatments should be approached.

There’s a lot of blame to go around when it comes to why drug costs are rising in dermatology. We’ll let the research do the finger pointing.

Do anonymous patient feedback systems create a situation of undue influence?

NYU researchers suggest a difference in the tumor progression of stage IV melanoma patients based on the initial clinical stage at original diagnosis.

For patients with severe AD, treatment with the systemic immunomodulator methotrexate mycophenolate mofetil is a viable option, according to a recent review of the drug.

A review of basic laser knowledge will help dermatologists improve operating room and patient safety as well as ensure optimal outcomes. One expert offers tips for assessing space, equipment and patients.

The options for tattoo removal are more numerous and more effective than ever. Picosecond technology, quad treatments, Perfluorodecalin, macrophage targeting, and Q-switched lasers allow people with ink regret more effective ways to return their skin to pre-tat status.

Research has demonstrated that staph aureus is in increased supply on the skin of atopic dermatitis patients coupled with less overall diversity in the number of bacteria on their skin, suggesting therapies that achieve balance in the skin microbiome could help to manage atopic dermatitis.

An expert debunks common myths and considers future possibilities for the use oftopical nanosilver in wound healing.